Company Performance Metrics
- Josephine Dorh: Co-Founder and CTO
- Neciah Dorh: Co-Founder and CEO
FluoretiQ is a medical device company designing simple and effective bacterial detection systems for rapid diagnosis of infection. They developing a new solution that combines proprietary nanomaterials and optical sensing technologies to enable the identification of harmful bacteria in minutes. The company nanotechnology utilizes receptor-mediated
sensing and Quantum-enhanced optics for the rapid identification of bacterial infection.
FluoretiQ developed NANOPLEXa rapid diagnostic platform that identifies and enumerates bacterial pathogens in less than 15 minutes. The NANOPLEXa ensures that patients receive the most effective antibiotic treatment from the start. Their products easy-to-use, providing clinicians with the data to support accurate-same-day diagnosis and more appropriate antibiotic selection.
FlouretiQ was founded in 2017 and is headquartered in Bristol, United Kingdom.
